Carregant...
Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment
The adverse side effects and toxicity caused by the non-targeted delivery of doxorubicin has emphasized the demand of emerging a targeted delivery system. The goal of this study is to enhance the delivery of doxorubicin by formulating an aptamer-labeled liposomal nanoparticle delivery system that wi...
Guardat en:
| Publicat a: | AAPS PharmSciTech |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995642/ https://ncbi.nlm.nih.gov/pubmed/32696338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-020-01743-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|